Loading…
CIK 0001056807 • 6 13F filings • May 15, 2025 – Aug 14, 2026
Import this data to Google Sheets with:
=jivedata("bvf-inc-il","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| 4D MOLECULAR THERAPEUTICS IN | COM | $38.3M | 1.0%Prev: 0.6% | 2,879,289 SH | Increased-1,750,000 SH |
| ABSCI CORPORATION | COM | $27.4M | 0.7% | 2,361,674 SH | New |
| AC IMMUNE SA | SHS | $47.2M | 1.2%Prev: 1.4% | 19,822,436 SH | Increased |
| ALKERMES PLC | SHS | $112.9M | 2.9% | 2,154,704 SH | New |
| ANNEXON INC | COM | $49.7M | 1.3%Prev: 0.6% | 8,698,173 SH | Increased+1,698,173 SH |
| ANTERIS TECHNOLOGIES GLOBAL | COM | $29.6M | 0.8% | 3,000,000 SH | New |
| AVALO THERAPEUTICS INC | COM NEW | $38.4M | 1.0%Prev: 0.2% | 2,075,545 SH | Increased+1,047,496 SH |
| CRESCENT BIOPHARMA INC. | COM | $49.5M | 1.3%Prev: 0.8% | 2,748,763 SH | Increased+1,360,900 SH |
| CULLINAN THERAPEUTICS INC | COM | $104.7M | 2.7%Prev: 1.5% | 5,750,683 SH | Increased |
| DISC MEDICINE INC | COM | $84.4M | 2.2% | 1,153,612 SH | New |
| ELEDON PHARMACEUTICALS INC | COM | $24.8M | 0.6%Prev: 0.6% | 6,293,282 SH | Increased |
| ENGENE THERAPEUTICS | *W EXP 10/31/202 | $274K | 0.0% | 945,402 SH | New |
| ENTERA BIO LTD | SHS | $4.3M | 0.1% | 2,425,000 SH | New |
| FOGHORN THERAPEUTICS INC | COM | $28.5M | 0.7%Prev: 0.9% | 5,842,000 SH | Increased+540,000 SH |
| GH RESEARCH PLC | ORDINARY SHARES | $232.5M | 5.9%Prev: 3.8% | 8,650,158 SH | Increased-177,554 SH |
| IMAGENEBIO INC | COM | $6.5M | 0.2% | 1,110,002 SH | New |
| IMMUNIC INC | COM NEW | $11.8M | 0.3% | 765,295 SH | New |
| IMMUNOCORE HLDGS PLC | ADS | $41.1M | 1.1%Prev: 1.1% | 1,294,463 SH | Increased+270,175 SH |
| INVENTIVA SA | ADS | $2.6M | 0.1%Prev: 0.1% | 686,040 SH | Increased |
| INVIVYD INC | COM | $24.6M | 0.6% | 28,165,000 SH | New |
| KURA ONCOLOGY INC | COM | $92.7M | 2.4%Prev: 1.6% | 8,445,769 SH | Increased+691,640 SH |
| KYMERA THERAPEUTICS INC | COM | $444.0M | 11.4%Prev: 8.6% | 3,872,052 SH | Increased-1,630,658 SH |
| MIRUM PHARMACEUTICALS INC | COM | $123.6M | 3.2%Prev: 5.0% | 1,056,027 SH | Decreased-1,705,306 SH |
| MOLECULAR PARTNERS AG | ADS | $5.1M | 0.1%Prev: 0.2% | 1,353,968 SH | Decreased |
| MONTE ROSA THERAPEUTICS INC | COM | $108.0M | 2.8%Prev: 0.9% | 4,460,886 SH | Increased-1,199,246 SH |
| MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | $311.5M | 8.0%Prev: 33.3% | 16,001,284 SH | Decreased-3,750,000 SH |
| NEKTAR THERAPEUTICS | COM NEW | $166.9M | 4.3% | 2,391,075 SH | New |
| OLEMA PHARMACEUTICALS INC | COM | $66.3M | 1.7%Prev: 0.8% | 5,295,893 SH | Increased |
| ONKURE THERAPEUTICS INC | COM CL A | $14.8M | 0.4% | 3,235,778 SH | New |
| PALVELLA THERAPEUTICS INC NE | COM | $102.8M | 2.6%Prev: 0.6% | 672,789 SH | Increased-23,766 SH |
| Q32 BIO INC | COM | $29.9M | 0.8% | 2,350,000 SH | New |
| RESEARCH ALLIANCE CORP III | ORD SHS CL A | $5.3M | 0.1% | 500,000 SH | New |
| REVOLUTION MEDICINES INC | COM | $555.3M | 14.2%Prev: 6.5% | 2,965,160 SH | Increased-2,017,224 SH |
| SAGIMET BIOSCIENCES INC | COM SER A | $19.3M | 0.5% | 2,500,000 SH | New |
| STOKE THERAPEUTICS INC | COM | $83.4M | 2.1% | 2,547,557 SH | New |
| STRUCTURE THERAPEUTICS INC | SPONSORED ADS | $180.7M | 4.6%Prev: 1.3% | 3,366,823 SH | Increased+1,595,406 SH |
| SUTRO BIOPHARMA INC | COM SHS | $41.6M | 1.1% | 1,251,788 SH | New |
| TENAX THERAPEUTICS INC | COM NEW | $4.9M | 0.1%Prev: 0.1% | 339,549 SH | Increased |
| TSCAN THERAPEUTICS INC | COM | $5.5M | 0.1%Prev: 0.3% | 5,564,290 SH | Decreased+338,216 SH |
| TYRA BIOSCIENCES INC | COM | $47.1M | 1.2%Prev: 1.3% | 1,476,196 SH | Increased-2,467,998 SH |
| X4 PHARMACEUTICALS INC | COM NEW | $10.4M | 0.3% | 2,233,742 SH | New |
| XENCOR INC | COM | $114.9M | 2.9%Prev: 0.8% | 7,133,720 SH | Increased+4,393,579 SH |
| XOMA ROYALTY CORPORATION | COM NEW | $322.7M | 8.3%Prev: 2.3% | 7,593,303 SH | Increased+5,003,000 SH |
| ZYMEWORKS INC | COM | $95.4M | 2.4%Prev: 1.9% | 3,649,142 SH | Increased-659,793 SH |
| 13F-HR |
| 0000921895-26-002163 |
| $3.91B |
| View |
| Aug 14, 2025 | Q2 2025 | 13F-HR | 0000921895-25-002281 | $2.80B | View |
| May 15, 2026 | Q1 2026 | 13F-HR | 0000921895-26-001382 | $3.14B | View |
| May 15, 2025 | Q1 2025 | 13F-HR | 0000921895-25-001528 | $2.45B | View |